News Related to Low Back Pain

Related coverage linked through entity extraction aliases.

FDA Approves First Posterior Motion-Preserving Device as DDD Pipeline Advances

Jul 01, 2026

The FDA approved the first posterior motion-preserving device for degenerative disc disease, while DiscGenics, Angitia, and BioRestorative advanced late-stage trials. ReGelTec reported positive HYDRAFIL data and CE Mark approval.

Gene Therapy for Knee Osteoarthritis Advances; India Plans Regulatory Framework

Mar 09, 2026

Five intra-articular gene therapy platforms for knee osteoarthritis are in human trials in the US, while India prepares regulatory guidelines for mRNA, gene and cell therapies to accelerate innovation.